BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23159297)

  • 1. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
    Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
    Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical sensitivity of four commonly used hCG point of care devices.
    Kamer SM; Foley KF; Schmidt RL; Greene DN
    Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
    Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
    Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
    Nerenz RD; Song H; Gronowski AM
    Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Hook-like effect" causes false-negative point-of-care urine pregnancy testing in emergency patients.
    Griffey RT; Trent CJ; Bavolek RA; Keeperman JB; Sampson C; Poirier RF
    J Emerg Med; 2013 Jan; 44(1):155-60. PubMed ID: 21835572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests.
    Cole LA; Ladner DG
    Clin Biochem; 2009 Feb; 42(3):168-75. PubMed ID: 18929550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of a false positive urine pregnancy test in a patient with membranoproliferative glomerulonephritis type I.
    Marzinke MA; Jarrar P; Atkinson M; Humphrey RL; Detrick B; Sokoll LJ
    Clin Chim Acta; 2012 Jan; 413(1-2):361-3. PubMed ID: 22024216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
    Milhorn D; Korpi-Steiner N
    Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for a quantitative urine hCG assay.
    Cole LA; Khanlian SA
    Clin Biochem; 2009 May; 42(7-8):676-83. PubMed ID: 19026624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
    Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
    Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
    Johnson S; Eapen S; Smith P; Warren G; Zinaman M
    J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-Negative Urine Human Chorionic Gonadotropin Testing in the Clinical Laboratory.
    Herskovits AZ; Chen Y; Latifi N; Ta RM; Kriegel G
    Lab Med; 2020 Jan; 51(1):86-93. PubMed ID: 31245816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of qualitative urinary hCG assays.
    Nickmans S; Vermeersch P; Van Eldere J; Billen J
    Acta Clin Belg; 2014 Aug; 69(4):277-9. PubMed ID: 24846178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance evaluation of the i-STAT Total β-human chorionic gonadotropin immunoassay.
    Sowder AM; Yarbrough ML; Nerenz RD; Mitsios JV; Mortensen R; Gronowski AM; Grenache DG
    Clin Chim Acta; 2015 Jun; 446():165-70. PubMed ID: 25916696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single serum test for measuring early pregnancy outcome with high predictive value.
    Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
    Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations.
    Lockwood CM; Grenache DG; Gronowski AM
    Thyroid; 2009 Aug; 19(8):863-8. PubMed ID: 19505185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performances of urine pregnancy tests on College of American Pathologists Survey specimens.
    Biesecker JL; Rippey JH
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):544-6. PubMed ID: 7282640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molar pregnancy with false negative urine hCG: the hook effect.
    Pang YP; Rajesh H; Tan LK
    Singapore Med J; 2010 Mar; 51(3):e58-61. PubMed ID: 20428735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of ELISA and latex agglutination tests for detection of human chorionic gonadotropin (hCG) in urine for pregnancy.
    Ambedkar SS; Deshpande BS; Naik SR
    Hindustan Antibiot Bull; 1988; 30(1-2):12-5. PubMed ID: 3170256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.